383 related articles for article (PubMed ID: 20030503)
1. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
2. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
4. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Blatta orientalis (Q) nasal gel formulation in milk aspiration induced eosinophilia.
Nimgulkar CC; Patil SD; Chauk DS
Pharm Dev Technol; 2009; 14(4):435-41. PubMed ID: 19552565
[TBL] [Abstract][Full Text] [Related]
6. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
Sharma S; Lohan S; Murthy RS
Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
[TBL] [Abstract][Full Text] [Related]
9. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
Zhao Y; Yue P; Tao T; Chen QH
Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
[TBL] [Abstract][Full Text] [Related]
10. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
Hu KL; Mei N; Feng L; Jiang XG
Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
[TBL] [Abstract][Full Text] [Related]
12. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
[TBL] [Abstract][Full Text] [Related]
13. Nose-to-brain delivery of tacrine.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
[TBL] [Abstract][Full Text] [Related]
14. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Charlton ST; Davis SS; Illum L
J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
[TBL] [Abstract][Full Text] [Related]
16. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Ved PM; Kim K
Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
[TBL] [Abstract][Full Text] [Related]
18. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
[TBL] [Abstract][Full Text] [Related]
19. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease.
Rao M; Agrawal DK; Shirsath C
Drug Dev Ind Pharm; 2017 Jan; 43(1):142-150. PubMed ID: 27533244
[TBL] [Abstract][Full Text] [Related]
20. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
